2m 2m 2m 2m 2m 2m 2m
ADVANCED BIOMED (ADVB)
NASDAQ
$3.55+$0.09 (+2.60%)
Price as of Oct 22, 2026 7:30 PM EDT- $6.2MMarket Cap
- -60.68%1-Year Change
- Diagnostics & ResearchIndustry
ADVANCED BIOMED (ADVB)
$3.55+$0.09 (+2.60%)
ADVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.46 | ||
Change | -$0.30 (-7.98%) | ||
Open | $3.65 | ||
High | $3.75 | ||
Low | $3.42 | ||
Previous Close | $3.76 | ||
Volume | 11,720 | ||
30-Day Average Volume | 34,885 | ||
1-Week Change | -29.10% | ||
1-Month Change | -45.77% | ||
1-Year Change | -60.68% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $10.6M | ||
Market Cap | $6.2M | ||
Enterprise Value | $4.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$488,942.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$488,830.00 | ||
EBITDA | -$479,504.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/20/2026 | ||
Earnings & Revenue